|

Conventional DAPT Clinical Trials

2 actively recruiting trials

▲ +1 trial since May 2026

Also known as: Unguided DAPT

Pipeline

Phase 4: 1

Top Sponsors

  • Zunyi Medical College1
  • IGLESIAS Juan Fernando1

Indications

  • Heart Disease2
  • Left Main Coronary Artery Stenosis1
  • CYP2C19 Polymorphism1
  • ACS - Acute Coronary Syndrome1

Other2 trials

CYP2C19 Genotype-Guided P2Y12 Receptor Inhibitor Selection After Complex Percutaneous Coronary Intervention
Phase 4
Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.